Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2888 of 3330
Next
>>
>
72176 to 72200 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF 10F	NM	-	Temsirolimus	MTOR	MTOR	0.213	uM	12254.144	0.6339	0.5702	1.8842
MCF 10F	NM	-	Temsirolimus	MTOR	MTOR	1.07	uM	12254.144	0.5724	0.4874	1.8842
MCF 10F	NM	-	Temsirolimus	MTOR	MTOR	5.33	uM	12254.144	0.6391	0.5770	1.8842
MCF 10F	NM	-	Temsirolimus	MTOR	MTOR	26.7	uM	12254.144	0.5181	0.4107	1.8842
MCF 10F	NM	-	Temsirolimus	MTOR	MTOR	133	uM	12254.144	0.1403	-0.2947	1.8842
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.000341	uM	10817.144	0.9620	0.9477	1.4640
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.00171	uM	10817.144	0.9622	0.9480	1.4640
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.00853	uM	10817.144	0.9837	0.9776	1.4640
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.0427	uM	10817.144	0.9516	0.9333	1.4640
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.213	uM	10817.144	0.9163	0.8841	1.4640
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	1.07	uM	10817.144	0.9440	0.9227	1.4640
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	5.33	uM	10817.144	0.8583	0.8017	1.4640
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	26.7	uM	10817.144	0.1926	-0.3507	1.4640
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	133	uM	10817.144	0.0077	-0.9282	1.4640
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.000341	uM	12365.168	1.0244	1.0221	2.1914
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.00171	uM	12365.168	0.9404	0.9447	2.1914
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.00853	uM	12365.168	1.0225	1.0204	2.1914
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.0427	uM	12365.168	0.9259	0.9309	2.1914
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	0.213	uM	12365.168	0.8037	0.8102	2.1914
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	1.07	uM	12365.168	0.8186	0.8254	2.1914
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	5.33	uM	12365.168	0.7761	0.7816	2.1914
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	26.7	uM	12365.168	0.2713	0.1029	2.1914
MCF12A	NM	Basal B	Temsirolimus	MTOR	MTOR	133	uM	12365.168	0.0095	-0.7608	2.1914
MCF7	HR+	Luminal	Temsirolimus	MTOR	MTOR	0.000341	uM	10997.144	0.9386	0.9030	1.2750
MCF7	HR+	Luminal	Temsirolimus	MTOR	MTOR	0.00171	uM	10997.144	0.9884	0.9819	1.2750

|<
<<
Previous
Page 2888 of 3330
Next
>>
>
72176 to 72200 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)